HtrA1 has been reported to be absent or substantially down-regulated in a variety of cancers during their progression, including gastric, breast, ovarian [6], endometrial [7] and hepatocellular [8] carcinomas, as well as mesothelioma [9] and melanoma [10]. The gene discussed is HTRA1; the disease is cancer.